Live Breaking News & Updates on Connect Bropharma

Stay updated with breaking news from Connect bropharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

5-Year Safety Data From Upadacitinib Trials Reported

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick. ....

United States , United Kingdom , Yale University , New Haven , Leo Pharma , Eli Lilly , Christopherg Bunick , Upadacitinib Rinvoq , Drug Administration , Revolutionizing Atopic Dermatitis Virtual , Ortho Dermatologics , Connect Bropharma , Atopic Dermatitis , Atopic Eczema , Herpes Zoster , Adolescent Medicine , Adolescent Health , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Body Mass Index , Clinical Research , Clinical Trials , Linical Studies ,